Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 121
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Am J Perinatol ; 34(7): 668-675, 2017 06.
Article in English | MEDLINE | ID: mdl-27926973

ABSTRACT

Objective To determine whether arterial umbilical cord gas (aUCG) pH, in anatomically normal-term infants, could select infants at risk for brain injury identified on magnetic resonance imaging (MRI). Study Design We performed a nested case-control within a prospective cohort of 8,580 women. Cases, with an aUCG pH < 7.10, were temporally, age, and sex matched to controls with an aUCG pH ≥ 7.20. Bi- and multivariable analyses compared the presence and severity of brain injury. Secondary analyses estimated whether elevated arterial base excess or lactate were associated with brain injury. Results Fifty-five cases were matched to 165 controls. There was no statistical difference in brain injury between the groups (adjusted odds ratio [aOR]: 1.8, 95% confidence interval [CI]: 0.7-4.4]). Base excess ≥ -8 mEq/L was not significantly associated with brain injury (p = 0.12). There was no increase in risk of injury based on elevation of arterial lactate ≥ 4 mmol /L (p = 1.00). Cases were significantly more likely to have an abnormal score in several domains of the Dubowitz neurologic examination. Conclusion The aUCG acid-base parameters alone are not sufficient clinical markers to identify term infants that might benefit from MRI of the brain to identify injury.


Subject(s)
Acidosis/diagnosis , Brain Injuries/diagnostic imaging , Brain Injuries/physiopathology , Fetal Blood/chemistry , Blood Gas Analysis/methods , Case-Control Studies , Female , Gestational Age , Humans , Hydrogen-Ion Concentration , Infant, Newborn , Logistic Models , Magnetic Resonance Imaging , Male , Missouri , Multivariate Analysis , Prospective Studies , Severity of Illness Index , Term Birth
2.
Hum Genet ; 134(4): 439-50, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25715684

ABSTRACT

Genetic studies have identified single nucleotide polymorphisms (SNPs) associated with the risk of prostate cancer (PC). It remains unclear whether such genetic variants are associated with disease aggressiveness. The NCI-SPORE Genetics Working Group retrospectively collected clinicopathologic information and genotype data for 36 SNPs which at the time had been validated to be associated with PC risk from 25,674 cases with PC. Cases were grouped according to race, Gleason score (Gleason ≤ 6, 7, ≥ 8) and aggressiveness (non-aggressive, intermediate, and aggressive disease). Statistical analyses were used to compare the frequency of the SNPs between different disease cohorts. After adjusting for multiple testing, only PC-risk SNP rs2735839 (G) was significantly and inversely associated with aggressive (OR = 0.77; 95 % CI 0.69-0.87) and high-grade disease (OR = 0.77; 95 % CI 0.68-0.86) in European men. Similar associations with aggressive (OR = 0.72; 95 % CI 0.58-0.89) and high-grade disease (OR = 0.69; 95 % CI 0.54-0.87) were documented in African-American subjects. The G allele of rs2735839 was associated with disease aggressiveness even at low PSA levels (<4.0 ng/mL) in both European and African-American men. Our results provide further support that a PC-risk SNP rs2735839 near the KLK3 gene on chromosome 19q13 may be associated with aggressive and high-grade PC. Future prospectively designed, case-case GWAS are needed to identify additional SNPs associated with PC aggressiveness.


Subject(s)
Polymorphism, Single Nucleotide , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Cohort Studies , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Male , Middle Aged , National Cancer Institute (U.S.) , Neoplasm Invasiveness , Risk Factors , United States
3.
Am J Obstet Gynecol ; 213(5): 681.e1-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26193688

ABSTRACT

OBJECTIVE: The purpose of this study was to identify electronic fetal monitoring patterns that are associated with neonatal respiratory morbidity. STUDY DESIGN: In an on-going prospective cohort study of >8000 consecutive term, vertex, nonanomalous singleton pregnancies during labor, we performed this analysis within the first 5000 women as a representative sample. Electronic fetal monitoring patterns in the 30 minutes preceding delivery were extracted by trained obstetrics research nurses, who were blinded to clinical data, using the National Institute of Child Health and Human Development system; the data were compared between those with respiratory morbidity and healthy infants (no morbidities). The primary outcome was neonatal respiratory morbidity, which was defined as either oxygen requirement at ≥6 hours of life or any mechanical ventilation in the first 24 hours. Multivariable logistic regression was used to adjust for confounders. RESULTS: Of 4736 neonates, 175 (3.4%) experienced respiratory morbidity. Most electronic fetal monitoring patterns were category II (96.6%; n = 4575). Baseline tachycardia (adjusted odds ratio [aOR], 2.9; 95% confidence interval [CI], 1.9-4.4), marked variability (aOR, 2.7; 95% CI, 1.5-5.0), and prolonged decelerations (aOR,2.7; 95% CI, 1.5-5.0) were significantly associated with an increased likelihood of term neonatal respiratory morbidity. Accelerations and persistent moderate variability were both significantly associated with a decreased likelihood of respiratory morbidity. CONCLUSION: Specific features of category II electronic fetal monitoring patterns make respiratory morbidity more likely in nonanomalous term infants. Tachycardia, marked variability, or prolonged decelerations before delivery can assist providers in anticipating the potential need for neonatal respiratory support.


Subject(s)
Cardiotocography , Respiratory Tract Diseases/diagnosis , Adult , Female , Heart Rate, Fetal/physiology , Humans , Infant, Newborn , Multivariate Analysis , Oxygen/administration & dosage , Pregnancy , Respiration, Artificial/statistics & numerical data , Tachycardia/epidemiology
4.
Am J Obstet Gynecol ; 213(3): 420.e1-5, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26026920

ABSTRACT

OBJECTIVE: The purpose of this study was to compare the first stage of labor progress in women who undergo an induction of labor after cesarean delivery with women who have spontaneous labor after cesarean delivery. STUDY DESIGN: We conducted a retrospective cohort study of consecutive women who had been admitted for delivery with a vertex-presenting fetus who achieved vaginal delivery after cesarean delivery. We compared women who underwent an induction of labor after cesarean delivery with women with spontaneous labor after cesarean delivery. Labor curves were constructed with a repeated-measures analysis; interval-censored regression was used to estimate the median time spent to dilate 1 cm, stratified by induction status, and adjusted by obesity, macrosomia, epidural, and previous vaginal delivery. RESULTS: Of 473 laboring women with a previous cesarean delivery, 234 women (49%) were induced. After adjustment for obesity, macrosomia, epidural, and previous vaginal delivery, women who underwent an induction had significantly longer labors than those women who experienced spontaneous labor. The median time to dilate from 4-10 cm took 5.6 hours (95% confidence interval, 1.8-18.0 hours) in the induction group and 3.2 hours (95% confidence interval, 1.0-10.3 hours) in the spontaneous labor group (P < .01). The time to progress 1 cm in dilation from 3-7 cm was different; however, after 7 cm, the time to progress 1 cm was not statistically different. CONCLUSION: Women who undergo an induction of labor after cesarean delivery have a longer latent labor phase, but a similar active phase than those women who experience spontaneous labor. When making the diagnosis of labor dystocia for women who undergo an induction of labor after cesarean delivery, clinicians should use the same normative standards for labor treatment of women without a previous cesarean delivery as has been shown in previous work.


Subject(s)
Labor, Induced , Trial of Labor , Vaginal Birth after Cesarean , Adult , Cohort Studies , Dystocia/diagnosis , Dystocia/etiology , Female , Humans , Labor Onset/physiology , Pregnancy , Regression Analysis , Retrospective Studies , Time Factors
5.
Am J Obstet Gynecol ; 212(6): 799.e1-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25634367

ABSTRACT

OBJECTIVE: The purpose of this study was to identify ante- and intrapartum risk factors for serious morbidity in term nonanomalous neonates. STUDY DESIGN: We analyzed the first 5000 subjects within an ongoing prospective cohort study of consecutive term births from 2010-2012. The primary outcome was a composite of serious neonatal morbidity defined as ≥1 cases of hypoxic ischemic encephalopathy, meconium aspiration with pulmonary hypertension, requirement of hypothermia therapy, respiratory distress syndrome, seizures, sepsis or suspected sepsis, or death. We calculated odds ratios for the composite morbidity that is associated with ante- and intrapartum factors. Multivariable logistic regression was used to estimate adjusted odds ratios. RESULTS: Of 5000 term nonanomalous births, 393 had the composite morbidity. Significant risk factors for morbidity were nulliparity, presence of meconium, first stage of labor >95th percentile, second stage of labor >95th percentile, pregestational diabetes mellitus, chronic hypertension, obesity, maternal intrapartum fever, and cesarean delivery. In contrast, induction of labor and gestational age ≥41 weeks were not associated with significant morbidity. CONCLUSION: We identified several significant risk factors for serious morbidity in term nonanomalous neonates. Clinicians may use these risk factors to help anticipate the potential need for additional neonatal support at delivery.


Subject(s)
Infant, Newborn, Diseases/epidemiology , Adult , Female , Humans , Infant, Newborn , Morbidity , Pregnancy , Prospective Studies , Risk Factors , Severity of Illness Index , Term Birth , Young Adult
6.
Am J Perinatol ; 32(9): 873-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25607225

ABSTRACT

OBJECTIVE: We aimed to estimate the effect of intrauterine growth restriction (IUGR) on electronic fetal monitoring (EFM) patterns in the second stage of labor. STUDY DESIGN: We performed a 5-year retrospective cohort study of consecutive singleton, non-anomalous, term gestations. We compared IUGR infants, those with a birth weight less than the 10th percentile, with non-IUGR infants, those greater than or equal to the 10th percentile. Our primary outcome was the EFM patterns in the 30 minutes before delivery. A secondary analysis was performed excluding infants with composite morbidity. Logistic regression was used to adjust for body mass index, race, nulliparity, induction, and protracted labor. RESULTS: Out of the 5,388 infants, 652 (12.1%) were IUGR. IUGR fetuses had less accelerations (29.0 vs. 35.9%, p < 0.01), even among apparently normal infants (29.0 vs. 36.4%, p < 0.01). IUGR fetuses had a higher risk of decelerations, and in all, IUGR accounted for 6% of late decelerations (attributable risk 0.06, 95% confidence interval 0.02-0.10). There was no significant association between IUGR and bradycardia or minimal variability. CONCLUSION: Growth restriction at term confers an increased risk of late decelerations, even in the absence of neonatal morbidity. EFM patterns may require different interpretations based on a priori risk and clinical factors.


Subject(s)
Cardiotocography/methods , Fetal Growth Retardation/physiopathology , Heart Rate, Fetal , Labor Stage, Second , Adolescent , Adult , Birth Weight , Female , Humans , Logistic Models , Pregnancy , Retrospective Studies , Young Adult
7.
Am J Perinatol ; 32(5): 497-502, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25539409

ABSTRACT

OBJECTIVE: The objective of this study was to estimate the association between time from uterine incision to delivery and hypoxic neonatal outcomes in nonanomalous term infants. METHODS: All women undergoing in-labor term cesarean deliveries (CDs) in the first 2 years of an ongoing prospective cohort study were included. The primary exposure was time in seconds from uterine incision to delivery. The primary outcome was a composite of hypoxia-associated neonatal outcomes, defined as at least one of: seizures, hypoxic ischemic encephalopathy, need for hypothermia treatment, and death within 7 days. RESULTS: Of 812 patients who underwent in-labor CD, the composite hypoxia outcome occurred in 18 (2.2%) neonates. There was no significant difference in the rate of hypoxic morbidity with increasing increments of 60 seconds from uterine incision to delivery (p = 0.35). There was a significantly increased risk of hypoxic morbidity in those delivered in the highest quintile (>240 seconds) compared with those in the lowest quintile (≤ 60 seconds) in cesareans performed for an indication other than nonreassuring fetal status (relative risk, 5.58; 95% confidence interval, 1.30-23.91). CONCLUSION: Overall, duration from uterine incision to delivery for in-labor cesareans of nonanomalous term infants was not associated with an increase in risk of hypoxia-associated morbidities.


Subject(s)
Cesarean Section/adverse effects , Delivery, Obstetric/adverse effects , Fetal Distress/etiology , Hypoxia/complications , Infant, Newborn, Diseases/etiology , Term Birth , Adult , Female , Humans , Hysterotomy , Infant, Newborn , Pregnancy , Pregnancy Outcome , Prospective Studies , Time Factors , Young Adult
8.
J Urol ; 191(6): 1733-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24345439

ABSTRACT

PURPOSE: Genome-wide association studies have identified an increasing number of single nucleotide polymorphisms associated with prostate cancer risk. Some of these genetic variants are also associated with serum prostate specific antigen levels and lower urinary tract symptoms, raising the question of whether they are truly prostate cancer biomarkers or simply lead to detection bias. Therefore, we determined whether single nucleotide polymorphisms associated with prostate cancer risk are more strongly associated with tumor or prostate volume. MATERIALS AND METHODS: The genotypes of 38 validated prostate cancer risk single nucleotide polymorphisms were determined in 1,321 white men who underwent radical prostatectomy. Univariate and multivariate analyses were performed to compare the relationship of single nucleotide polymorphism frequency with total prostate and tumor volumes. RESULTS: On multivariate analysis 2 single nucleotide polymorphisms on chromosome 8q24, rs16901979 (A) and rs6983267 (G), were significantly associated with increased tumor volume (p=0.01 and 0.02, respectively). In contrast, rs17632542 (T) near the PSA gene on 19q13 was associated with significantly lower tumor volume and rs10788160 (A) on 10q26 was associated with significantly larger prostate volume (p=0.02 and 0.01, respectively). CONCLUSIONS: Analysis of 38 single nucleotide polymorphisms associated with prostate cancer risk revealed a significant association between several on chromosome 8q24 and increased tumor volume but not prostate volume. This suggests that they are bona fide markers of prostate cancer susceptibility and possibly more aggressive disease. Other prostate cancer risk alleles are associated with prostate specific antigen and increased prostate or decreased tumor volume, suggesting detection bias due to their phenotypic influence.


Subject(s)
Chromosomes, Human, Pair 8/genetics , DNA, Neoplasm/genetics , Genetic Predisposition to Disease , Neoplasm Staging , Polymorphism, Genetic , Prostate/pathology , Prostatic Neoplasms/genetics , Alleles , Biopsy , Follow-Up Studies , Genetic Variation , Genome-Wide Association Study , Genotype , Humans , Male , Middle Aged , Organ Size , Prostatectomy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , Retrospective Studies
9.
Reprod Biomed Online ; 29(1): 131-5, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24813751

ABSTRACT

The aim of this study was to determine whether practice in states with infertility insurance mandates is associated with physician-reported practice patterns regarding hydrosalpinx management in assisted reproduction clinics. A cross-sectional, internet-based survey of 442 members of Society for Reproductive Endocrinology and Infertility or Society of Reproductive Surgeons was performed. Physicians practising in states without infertility insurance mandates were more likely to report performing diagnostic surgery after an inconclusive hysterosalpingogram than physicians practising in states with mandates (RR 1.2, 95% CI 1.1-1.3, P < 0.01). Additionally, respondents in states without mandates were more likely to report that, due to lack of infertility insurance coverage, they did not perform salpingectomy (SPX) or proximal tubal occlusion (PTO) before assisted reproduction treatment (RR 1.4, 95% CI 1.1-1.8, P = 0.01). Finally, respondents in states without mandates were less likely to report that the presence of assisted reproduction treatment coverage determined the urgency with which they pursued SPX or PTO before treatment (RR 0.7, 95% CI 0.5-1.0, NS). These results persisted after controlling for physician years in practice, age and clinic volume. In conclusion, self-reported physician practice interventions for hydrosalpinges before assisted reproduction treatment may be associated with state-mandated infertility insurance. Fallopian tube dysfunction is a known cause of infertility and severe dysfunction is manifested by dilation and occlusion, known as hydrosalpinx. Outcomes with assisted reproductive techniques (ART) are lower when hydrosalpinges are present and while there are several theories for this, reproductive specialist recommend "neutralizing" the tube either by occlusion or removal in order to enhance pregnancy rates. In the United States, coverage for infertility services is not uniform with only 15 states having some legislation requiring infertility benefits. Some states where ART is covered liberally, physicians might have different practice patterns related to the neutralization of hydrosalpinges compared to those who are in non -mandated states. We utilized a survey of over 400 providers in the United States to examine their practice patterns as it relates to hydrosalpinges based on which state they practice in and whether or not that state has mandated coverage of not.


Subject(s)
Fallopian Tube Diseases/therapy , Insurance Coverage , National Health Programs/trends , Reproductive Medicine/trends , Sterilization, Tubal/statistics & numerical data , Cross-Sectional Studies , Female , Fertilization in Vitro , Humans , Reproductive Techniques, Assisted/economics , Sterilization, Tubal/economics , United States
10.
Am J Obstet Gynecol ; 210(6): 536.e1-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24361789

ABSTRACT

OBJECTIVE: The objective of the study was to determine the threshold for defining abnormal labor that is associated with adverse maternal and neonatal outcomes. STUDY DESIGN: This study consisted of a retrospective cohort of all consecutive women admitted at a gestation of 37.0 weeks or longer from 2004 to 2008 who reached the second stage of labor. The 90th, 95th, and 97th percentiles for progress in the first stage of labor were determined specific for parity and labor onset. Women with a first stage above and below each centile were compared. Maternal outcomes were cesarean delivery in the second stage, operative delivery, prolonged second stage, postpartum hemorrhage, and maternal fever. Neonatal outcomes were a composite of the following: admission to level 2 or 3 nursery, 5 minute Apgar less than 3, shoulder dystocia, arterial cord pH of less than 7.0, and a cord base excess of -12 or less. RESULTS: Of the 5030 women, 4534 experienced first stage of less than the 90th percentile, 251 between the 90th and 94th percentiles, 102 between the 95th and 96th percentiles, and 143 at the 97th percentile or greater. Longer labors were associated with an increased risk of a prolonged second stage, maternal fever, the composite neonatal outcome, shoulder dystocia, and admission to a level 2 or 3 nursery (P < .01). Depending on the cutoff used, 29-30 cesarean deliveries would need to be performed to prevent 1 shoulder dystocia. CONCLUSION: Although women who experience labor dystocia may ultimately deliver vaginally, a longer first stage of labor is associated with adverse maternal and neonatal outcomes, in particular shoulder dystocia. This risk must be balanced against the risks of cesarean delivery for labor arrest.


Subject(s)
Delivery, Obstetric/standards , Dystocia/etiology , Labor Stage, First/physiology , Obstetric Labor Complications , Adult , Apgar Score , Cesarean Section/statistics & numerical data , Cohort Studies , Delivery, Obstetric/adverse effects , Dystocia/diagnosis , Female , Humans , Infant, Newborn , Labor Stage, Second , Male , Postpartum Hemorrhage , Pregnancy , ROC Curve , Retrospective Studies , Time Factors
11.
BJU Int ; 114(6b): E50-E55, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24712975

ABSTRACT

OBJECTIVE: To evaluate whether genetic correction using the genetic variants prostate-specific antigen (PSA)-single nucleotide polymorphisms (SNPs) could reduce potentially unnecessary and/or delayed biopsies in African-American men. SUBJECTS AND METHODS: We compared the genotypes of four PSA-SNPs between 964 Caucasian and 363 African-American men without known prostate cancer (PCa). We adjusted the PSA values based on an individual's PSA-SNP carrier status, and calculated the percentage of men that would meet commonly used PSA thresholds for biopsy (≥ 2.5 or ≥ 4.0 ng/mL) before and after genetic correction. Potentially unnecessary and delayed biopsies were defined as those men who were below and above the biopsy threshold after genetic correction, respectively. RESULTS: Overall, 349 (96.1%) and 354 (97.5%) African-American men had measured PSA levels <2.5 and <4.0 ng/mL. Genetic correction in African-American men did not avoid any potentially unnecessary biopsies, but resulted in a significant (P < 0.001) reduction in potentially delayed biopsies by 2.5% and 3.9%, based on the biopsy threshold level. CONCLUSIONS: There are significant differences in the influence of the PSA-SNPs between African-American and Caucasian men without known PCa, as genetic correction resulted in an increased proportion of African-American men crossing the threshold for biopsy. These results raise the question of whether genetic differences in PSA might contribute to delayed PCa diagnosis in African-American men.


Subject(s)
Black or African American/genetics , Delayed Diagnosis/prevention & control , Endoscopic Ultrasound-Guided Fine Needle Aspiration/statistics & numerical data , Prostate-Specific Antigen/genetics , Prostatic Neoplasms/genetics , Unnecessary Procedures , White People/genetics , Aged , Early Detection of Cancer , Genotype , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Prostate-Specific Antigen/blood , Prostatic Neoplasms/pathology
12.
Am J Perinatol ; 31(9): 753-8, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24338116

ABSTRACT

OBJECTIVE: Compare labor progression in first and second stages in women < 18 years with those ≥18 years. STUDY DESIGN: Retrospective cohort study of consecutive women at term that reached the second stage of labor between 2004 and 2008. The first stage in women < 18 years was compared with women ≥18 years. Average labor curves were constructed and median time spent to progress 1 cm in dilation and total time from 4 to 10 cm was estimated. Time spent pushing and total duration of second stage were compared between groups. Analyses were then stratified by parity. RESULTS: There was no significant difference in progress of the first stage of labor between women < 18 years and those ≥18 years. In the second stage, nulliparous teenage women were less likely to have a duration > 60 or 120 minutes. CONCLUSION: Laboring women < 18 years should be managed with the same expectations of labor as women ≥18 years.


Subject(s)
Labor Stage, First/physiology , Labor Stage, Second/physiology , Pregnancy/physiology , Adolescent , Age Factors , Female , Humans , Parity , Retrospective Studies , Time Factors , Young Adult
13.
Am J Perinatol ; 31(4): 315-20, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23775065

ABSTRACT

OBJECTIVE: To compare first-stage labor patterns in women in preterm labor to those in labor at term. STUDY DESIGN: We performed a retrospective cohort study of consecutive women admitted from 2004 to 2008 with viable (≥ 24 weeks) vertex singleton gestations who reached the second stage of labor. Labor curves for preterm and term labor were created using a repeated-measures analysis with polynomial modeling. Interval-censored regression was used to estimate and compare median time of progression of labor. Multivariable analyses were performed to adjust for smoking, obesity (body mass index ≥ 30), induction, and nulliparity. The adjusted model was stratified by parity and induction of labor. RESULTS: Of 5,612 consecutive births, 224 were preterm (<37 weeks) and 5,388 were term (≥ 37 weeks). Preterm first-stage labor progressed significantly faster than term labor (median time 4 to 10 cm: 3.3 hours versus 4.5 hours, p < 0.01). When stratified by parity, preterm labor progressed significantly more rapidly than term labor in both nulliparous and multiparous women (median time 4 to 10 cm: 3.7 hours versus 4.9 hours [p = 0.04] in nulliparous women and 2.5 hours versus 4.3 hours [p = 0.01] in multiparous women). CONCLUSION: Women in preterm labor progress more rapidly through the first stage of labor than women at term.


Subject(s)
Dystocia/physiopathology , Labor Stage, First/physiology , Obstetric Labor, Premature/physiopathology , Adolescent , Adult , Case-Control Studies , Cohort Studies , Female , Humans , Labor, Induced , Models, Statistical , Multivariate Analysis , Obesity , Parity , Pregnancy , Regression Analysis , Retrospective Studies , Smoking , Time Factors , Young Adult
14.
J Urol ; 189(5): 1697-701, 2013 May.
Article in English | MEDLINE | ID: mdl-23246478

ABSTRACT

PURPOSE: Recent studies have identified genetic variants associated with increased serum prostate specific antigen concentrations and prostate cancer risk, raising the possibility of diagnostic bias. By correcting for the effects of these variants on prostate specific antigen, it may be possible to create a personalized prostate specific antigen cutoff to more accurately identify individuals for whom biopsy is recommended. Therefore, we determined how many men would continue to meet common biopsy criteria after genetic correction of their measured prostate specific antigen concentrations. MATERIALS AND METHODS: The genotypes of 4 single nucleotide polymorphisms previously associated with serum prostate specific antigen levels (rs2736098, rs10788160, rs11067228 and rs17632542) were determined in 964 healthy Caucasian volunteers without prostate cancer. Genetic correction of prostate specific antigen was performed by dividing an individual's prostate specific antigen value by his combined genetic risk. Analyses were used to compare the percentage of men who would meet commonly used biopsy thresholds (2.5 ng/ml or greater, or 4.0 ng/ml or greater) before and after genetic correction. RESULTS: Genetic correction of serum prostate specific antigen results was associated with a significantly decreased percentage of men meeting biopsy thresholds. Genetic correction could lead to a 15% or 20% relative reduction in the total number of biopsies using a biopsy threshold of 2.5 ng/ml or greater, or 4.0 ng/ml or greater, respectively. In addition, genetic correction could result in an 18% to 22% reduction in the number of potentially unnecessary biopsies and a 3% decrease in potentially delayed diagnoses. CONCLUSIONS: Our results suggest that 4 single nucleotide polymorphisms can be used to adjust a man's measured prostate specific antigen concentration and potentially delay or prevent unnecessary prostate biopsies in Caucasian men.


Subject(s)
Genetic Variation , Polymorphism, Single Nucleotide , Prostate-Specific Antigen/blood , Prostate-Specific Antigen/genetics , Prostatic Neoplasms/blood , Prostatic Neoplasms/genetics , Aged , Biopsy/statistics & numerical data , Humans , Male , Middle Aged , Precision Medicine , Prostatic Neoplasms/pathology , Unnecessary Procedures/statistics & numerical data
15.
Am J Obstet Gynecol ; 208(5): 378.e1-5, 2013 May.
Article in English | MEDLINE | ID: mdl-23380264

ABSTRACT

OBJECTIVE: We sought to estimate the association between maternal seizure disorder and adverse pregnancy outcomes. STUDY DESIGN: We performed a retrospective cohort study of singleton, nonanomalous pregnancies. Women with self-reported seizure disorder were compared to women without medical problems. The primary outcome was intrauterine growth restriction (IUGR) <10th percentile. Secondary outcomes included IUGR <5th percentile, stillbirth, preeclampsia, and preterm delivery. A sensitivity analysis was performed using women who reported using antiepileptics to estimate the impact of disease severity on pregnancy outcomes. RESULTS: Of 47,118 women, 440 reported a seizure disorder. Women with seizure disorder were not at increased risk of IUGR <10th percentile (adjusted odds ratio, 1.11; 95% confidence interval, 0.82-1.50), IUGR <5th percentile, stillbirth, preeclampsia, or preterm delivery. The results were similar in the sensitivity analysis of women taking antiseizure medications. CONCLUSION: Our results suggest women with a seizure disorder are not at increased risk of IUGR, stillbirth, preeclampsia, or preterm delivery.


Subject(s)
Epilepsy , Pregnancy Complications , Pregnancy Outcome , Adult , Anticonvulsants/therapeutic use , Case-Control Studies , Epilepsy/drug therapy , Female , Fetal Growth Retardation , Follow-Up Studies , Humans , Incidence , Logistic Models , Pre-Eclampsia/epidemiology , Pre-Eclampsia/etiology , Pregnancy , Pregnancy Complications/drug therapy , Pregnancy Complications/epidemiology , Pregnancy Complications/etiology , Premature Birth/epidemiology , Premature Birth/etiology , Retrospective Studies , Risk Factors , Self Report , Severity of Illness Index , Stillbirth/epidemiology
16.
Am J Obstet Gynecol ; 209(1): 38.e1-6, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23562354

ABSTRACT

OBJECTIVE: The purpose of this study was to estimate the impact of internal monitors (fetal scalp electrode [FSE] and intrauterine pressure catheter [IUPC]) on maternal and neonatal outcomes. STUDY DESIGN: The study comprised a retrospective cohort of all women who were admitted for labor from 2004-2008. Women with internal monitors (FSE, IUPC, or both) were compared with women without internal monitors. Maternal outcomes were maternal fever and cesarean delivery. Neonatal outcomes were a composite of 5-minute Apgar score of ≤3, cord pH <7.1, cord base excess ≤-12, or admission to level 3 nursery. Logistic regression was performed to estimate the impact of internal monitors with adjustment for confounding variables, including time in labor. RESULTS: Of 6445 subjects, 3944 women (61.2%) had internal monitors. Women with internal monitors were more likely to have a fever than women without internal monitors (11.7% vs 4.5%; adjusted odds ratio [AOR], 2.0; 95% confidence interval [CI], 1.6-2.5). FSE alone was not associated with an increased risk of fever (AOR, 1.5; 95% CI, 1.0-2.1), but IUPC alone was (AOR, 2.4; 95% CI, 1.8-3.2). The risk of cesarean delivery was higher in women with internal monitors (18.6% vs 9.7%; AOR, 1.3; 95% CI, 1.0-1.5). Risk of cesarean delivery was lower in women with an FSE alone (AOR, 0.5; 95% CI, 0.4-0.7) but higher in women with both an FSE and an IUPC (AOR, 1.6; 95% CI, 1.4-2.0). Risk of the composite neonatal outcome was not higher in women with internal monitors (3.3% vs 3.6%; AOR, 0.8; 95% CI, 0.6-1.1). CONCLUSION: Routine use of an IUPC in laboring patients should be avoided because of an increased risk of maternal fever.


Subject(s)
Cesarean Section/statistics & numerical data , Fetal Monitoring/instrumentation , Fever/etiology , Labor, Obstetric/physiology , Obstetric Labor Complications/etiology , Adult , Apgar Score , Female , Fetal Monitoring/adverse effects , Fetal Monitoring/methods , Humans , Infant, Newborn , Logistic Models , Middle Aged , Obstetric Labor Complications/diagnosis , Obstetric Labor Complications/microbiology , Odds Ratio , Pregnancy , Retrospective Studies , Risk Assessment , Streptococcal Infections/etiology , Streptococcus agalactiae/pathogenicity
17.
Am J Obstet Gynecol ; 208(5): 393.e1-5, 2013 May.
Article in English | MEDLINE | ID: mdl-23369936

ABSTRACT

OBJECTIVE: We sought to determine the perinatal risks associated with growth discordance in appropriately grown twin gestations. STUDY DESIGN: We conducted a retrospective cohort study of all twin gestations excluding those complicated by monoamnionicity, twin-twin transfusion syndrome, structural anomalies, selective reduction, or a birthweight <10th percentile. Growth discordance was defined as ≥20%. Outcomes considered were stillbirth, preterm delivery <34 weeks and <28 weeks, and admission to the neonatal intensive care unit. Analyses were stratified by chorionicity. RESULTS: Of 895 included dichorionic pregnancies, 63 (7.0%) were discordant. Discordant dichorionic twins were not at increased risk of preterm delivery <34 weeks (34.9% vs 25.6%; relative risk [RR], 1.4; 95% confidence interval [CI], 1.0-1.9), preterm delivery <28 weeks (3.2% vs 2.8%; RR, 1.1; 95% CI, 0.3-4.8), or admission to intensive care (26.9% vs 23.5%; RR, 1.5; 95% CI, 1.0-2.3). We had >90% power to detect a 2.5-fold increase in preterm delivery and admission to the neonatal intensive care unit in dichorionic twins. Of 250 monochorionic pregnancies, 23 (9.2%) were discordant. Monochorionic twin pregnancies were at increased risk of preterm delivery <34 weeks (65.2% vs 26.4%; RR, 2.5; 95% CI, 1.7-3.6), preterm delivery <28 weeks (34.8% vs 4.0%; RR, 8.8; 95% CI, 3.7-20.5), and admission to intensive care (68.2% vs 23.3%; RR, 2.9; 95% CI, 2.0-4.3). CONCLUSION: In appropriately grown twins, growth discordance is a risk factor for adverse perinatal outcomes in monochorionic, but not dichorionic, twins. Discordant monochorionic twins may benefit from increased antenatal surveillance.


Subject(s)
Fetal Development , Pregnancy Outcome , Pregnancy, Twin , Twins, Dizygotic , Twins, Monozygotic , Adult , Cohort Studies , Female , Humans , Infant, Newborn , Intensive Care, Neonatal/statistics & numerical data , Pregnancy , Pregnancy Outcome/epidemiology , Premature Birth/epidemiology , Premature Birth/etiology , Retrospective Studies , Risk Factors , Stillbirth/epidemiology
18.
Am J Obstet Gynecol ; 208(1): 56.e1-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23098666

ABSTRACT

OBJECTIVE: We sought to estimate the risks of adverse pregnancy outcomes associated with early vaginal bleeding in twin pregnancies. STUDY DESIGN: In a retrospective cohort study of consecutive twin pregnancies undergoing anatomic survey, we compared women who reported vaginal bleeding at <22 weeks to those who did not. Exclusion criteria included monoamniotic pregnancies, twin-to-twin transfusion syndrome, and placenta previa. Primary outcomes included preeclampsia, abruption, preterm premature rupture of membranes (PPROM), preterm birth <34 weeks, and intrauterine growth restriction. RESULTS: Of 2106 pregnancies meeting inclusion criteria, 175 reported vaginal bleeding. Twin pregnancies with early vaginal bleeding had significantly higher risks of abruption, PPROM, and preterm birth compared to twin pregnancies without bleeding. The findings were similar when twin pairs were stratified by parity or maternal comorbidities. CONCLUSION: Twin pregnancies complicated by vaginal bleeding in early pregnancy have an increased risk of abruption, PPROM, and preterm birth <34 weeks.


Subject(s)
Fetal Membranes, Premature Rupture/etiology , Fetofetal Transfusion/complications , Pregnancy Outcome , Pregnancy, Twin , Premature Birth/etiology , Uterine Hemorrhage/complications , Adult , Female , Humans , Pregnancy , Retrospective Studies , Risk , Twins
19.
Am J Obstet Gynecol ; 208(3): 226.e1-7, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23333552

ABSTRACT

OBJECTIVE: Bacteria have been identified in different regions of the placenta. Here, we tested the hypothesis that the maternal basal plate of the placenta harbors microbes that may be associated with adverse pregnancy outcomes. STUDY DESIGN: We performed a cross-sectional study of pregnancies from a single tertiary care hospital. Maternal medical and obstetric characteristics were obtained and pregnancies followed up prospectively for outcomes and placental collection. After delivery, systematic random sampling of the placental basal plate was performed. Paraffin sections of basal plates were stained with 4 histologic stains and scored for morphological evidence of bacteria. RESULTS: Of 195 total patients in the study, Gram-positive and -negative intracellular bacteria of diverse morphologies were documented in the basal plates of 27% of all placentas. Of the patients, 35% delivered preterm. No difference was noted between placental basal plates from preterm or term gestations. Intracellular bacteria were found in the placental basal plates of 54% spontaneous preterm deliveries <28 weeks, and in 26% of term spontaneous deliveries (P = .02). Intracellular bacteria were also documented in placentas without clinical or pathologic chorioamnionitis. CONCLUSION: A total of 27% of placentas demonstrated intracellular bacteria in the placental basal plate using morphological techniques. Thus, the maternal basal plate is a possible source of intrauterine colonization and placental pathological examination could include examination for bacteria in this important maternal-fetal interface.


Subject(s)
Bacteria/isolation & purification , Chorioamnionitis/microbiology , Placenta/microbiology , Premature Birth/microbiology , Adult , Chorioamnionitis/pathology , Cross-Sectional Studies , Female , Gestational Age , Humans , Maternal Age , Placenta/pathology , Pregnancy , Premature Birth/pathology
20.
J Ultrasound Med ; 32(4): 625-30, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23525387

ABSTRACT

OBJECTIVES: We aimed to determine the accuracy of sonographic formulas for estimating birth weight in twin pregnancies. METHODS: We conducted a retrospective cohort study of consecutive twin pregnancies undergoing sonography at within 1 week of delivery. Pregnancies were included if biometric measurements and birth weight were available and excluded if anomalies were present. Estimated fetal weight was calculated using three sonographic formulas: two derived from singletons (Hadlock and Shepard) and one from twins (Ong). The correlation between estimated fetal weight and birth weight was determined using the Pearson correlation coefficient. The accuracy of each formula (bias) was assessed using the mean percentage error [(estimated fetal weight - birth weight)/birth weight × 100], and the precision (random error) was estimated from the standard deviation of the percentage error. The screening efficiency of each formula for intrauterine growth restriction, defined as below the 10th percentile on the Alexander growth standard, was assessed. The effect of twin presentation was determined using a paired analysis. RESULTS: Of 1744 consecutive twin pregnancies, 270 (540 infants) met inclusion criteria. The estimated fetal weight of all 3 formulas strongly correlated with the birth weight (Pearson r = 0.90 for Hadlock, 0.87 for Shepard, and 0.92 for Ong). Each formula had similar sensitivity (65%-70%) and specificity (85%-90%) for intrauterine growth restriction. For each formula, the correlation coefficient was similar between twins A and B (Pearson r = 0.85-0.93); however, the estimated fetal weight for twin A tended to underestimate birth weight, whereas the estimated fetal weight for twin B tended to overestimate birth weight. CONCLUSIONS: Three widely used estimated fetal weight formulas, two derived from singletons and one from twins, perform equally well in estimating birth weight in twin gestations.


Subject(s)
Birth Weight , Fetal Weight , Twins , Ultrasonography, Prenatal , Adult , Female , Humans , Pregnancy , Pregnancy Trimester, Second , Reproducibility of Results , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL